This is a research that will investigate the safety and efficacy of virgin coconut oil(VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)
This study will be a randomized controlled trial among hospitalized COVID-19 patients,
aged 18 years old and above, admitted at the Philippine General hospital. Patients will
be grouped into the following:
1. Group receiving standard of care
2. Group receiving standard of care plus virgin coconut oil (15ml, 3x/day for 2 weeks)
as adjunctive therapy.
Patients will be observed as regards to primary outcomes such as recovery/resolution of
symptoms and duration of hospital stay
Drug: Virgin Coconut Oil
Oral supplementation of virgin coconut oil to COVID-19 patients
Other Name: VCO
Inclusion Criteria:
- symptomatic and asymptomatic COVID-19 hospitalized patients
- has laboratory-confirmed illness during the time of recruitment
- able to take food and medicines enterally
Exclusion Criteria:
- uncontrolled or newly diagnosed diabetes mellitus
- with chronic heart disease
- having elevated lipid profile at baseline (admission)
Philippine General Hospital
Manila, Metro Manila, Philippines